GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical (Vivasure) is pleased to announce the successful enrollment of the first patient in the Frontier IV clinical study, a non-randomized multicenter international trial, designed to expand the indications of its proprietary PerQseal large arteriotomy closure…
Source: BioSpace